|
A less aggressive
approach to looking at the intestine for early signs of colorectal
cancer may be a more practical screening approach and thereby
save lives, according to a report in the Journal of the National
Cancer Institute.
The report
comes from Italian researchers conducting the SCORE trial, a multicenter
study seeking to measure whether a one-time sigmoidoscopy examination
at age 60 is an acceptable alternative to a more invasive colonoscopy
and regular follow-up screenings.
The American
Cancer Society recommends that starting at age 60, every adult
undergo a colonoscopy every 10 years. This requires that the patient
undergo sedation while the doctor inserts a lighted, flexible
tube to examine the entire intestine for polyps.
Sigmoidoscopy
is much less demanding because it uses a shorter tube that inspects
only the lower third of the colon for suspicious growths or precancerous
polyps. About two-thirds of cancers are found in this area.
The theory
being tested by the Italian study is that the less aggressive
approach -- a one-time sigmoidoscopy rather than regular colonoscopies
-- may result in many more screenings, thus saving lives even
though fewer precancerous growths are detected.
In the report,
researchers said they mailed a questionnaire to a random sample
of 236,568 people aged 55 to 64 years to assess their eligibility
for and interest in screening, and almost a quarter of these responded.
They ultimately enrolled 34,292 in the trial, and assigned half
to have a sigmoidoscopy.
Of the patients
examined, colorectal cancers were found at a rate of 5.4 per thousand,
according to the researchers.
But perhaps
as important, the researchers reported that the pain associated
with sigmoidoscopy was described as mild or less than expected
by 83.3 percent of those screened.
"Sigmoidoscopy
screening is generally acceptable to recipients and saf,"
the researchers concluded. "The high yield of advanced adenomas
is consistent with the projected impact of sigmoidoscopy screening
on colorectal cancer incidence."
Other
Sources: Journal of the National Cancer Institute
|